(Q54365116)

28 May 2018

title

Collagen triple helix repeat containing-1 inhibits transforming growth factor-b1-induced collagen type I expression in keloid. (English)

1 reference

28 May 2018

author name string

Li J

1

1 reference

28 May 2018

Cao J

2

1 reference

28 May 2018

Li M

3

1 reference

28 May 2018

Yu Y

4

1 reference

28 May 2018

Yang Y

5

1 reference

28 May 2018

Xiao X

6

1 reference

28 May 2018

Wu Z

7

1 reference

28 May 2018

Wang L

8

1 reference

28 May 2018

Tu Y

9

1 reference

28 May 2018

Chen H

10

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 May 2011

1 reference

28 May 2018

British Journal of Dermatology

published in

1 reference

28 May 2018

volume

164

1 reference

28 May 2018

issue

5

1 reference

28 May 2018

page(s)

1030-1036

1 reference

28 May 2018

Treatment of keloids and hypertrophic scars

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

New Therapies for the Management of Keloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

On the nature of hypertrophic scars and keloids: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

The molecular basis of keloid and hypertrophic scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Autocrine growth factor production by fetal, keloid, and normal dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Myofibroblasts and mechano-regulation of connective tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Tissue repair and stem cell renewal in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Chronic wounds: pathophysiologic and experimental considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Intracellular localization of Cthrc1 characterizes differentiated smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Is there an ideal animal model to study hypertrophic scarring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

Establishment of a hypertrophic scar model by transplanting full-thickness human skin grafts onto the backs of nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10215.X

10.1111/J.1365-2133.2011.10215.X

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018